Literature DB >> 1081577

Abnormal ratio of membrane immunoglobulin classes in mice with an X-linked B-lymphocyte defect.

F D Finkelman, A H Smith, I Scher, W E Paul.   

Abstract

CBA/N mice have an X-linked genetic defect in B-lymphocyte function manifested by inability to make antibody responses to T-independent antigens. Plasma membrane immunoglobulin (Ig) on spleen, lymph node, and Peyer's patch cells was analyzed by lactoperoxidase-catalyzed iodination, NP-40 extraction, specific immunoprecipitation, and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. These studies indicated that the X-linked immune defect was associated, in all three cell types, with a decrease in the ratio of cell membrane IgD analog to cell membrane IgM. This suggests either that IgD analog may be important in initiation of T-independent antibody responses or that CBA/N mice lack a subpopulation of B cells specialized to respond to T-independent antigens, and that these cells are relatively rich in plasma membrane IgD analog.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081577      PMCID: PMC2189974          DOI: 10.1084/jem.142.5.1316

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  The genetics of the immune response to a synthetic double-stranded RNA in a mutant CBA mouse strain.

Authors:  I Scher; M M Frantz; A D Steinberg
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Candidate for immunoglobulin D present on murine B lymphocytes.

Authors:  E R Abney; R M Parkhouse
Journal:  Nature       Date:  1974-12-13       Impact factor: 49.962

4.  Guinea pig immune response-related histocompatibility antigens. Partial characterization and distribution.

Authors:  F D Findelman; E M Shevach; E S Vitetta; I Green; W E Paul
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

5.  X-linked B-lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defect.

Authors:  I Scher; A D Steinberg; A K Berning; W E Paul
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

6.  X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells.

Authors:  I Scher; A Ahmed; D M Strong; A D Steinberg; W E Paul
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

7.  Cell surface immunoglobulin. X. Identification of an IgD-like molecule on the surface of murine splenocytes.

Authors:  U Melcher; E S Vitetta; M McWilliams; M E Lamm; J M Phillips-Quagliata; J W Uhr
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

8.  Cell surface immunoglobulin. XI. The appearance of an IgD-like molecule on murine lymphoid cells during ontogeny.

Authors:  E S Vitetta; U Melcher; M McWilliams; M E Lamm; J M Phillips-Quagliata; J W Uhr
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

9.  Cell surface immunoglobulin. II. Isolation and characterization of immunoglobulin from mouse splenic lymphocytes.

Authors:  E S Vitetta; S Baur; J W Uhr
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

10.  Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness.

Authors:  D F Amsbaugh; C T Hansen; B Prescott; P W Stashak; D R Barthold; P J Baker
Journal:  J Exp Med       Date:  1972-10-01       Impact factor: 14.307

  10 in total
  17 in total

1.  A novel Tth111I restriction fragment length polymorphism (RFLP) allows tracing of X-chromosome inactivation in the (Xid) heterozygote.

Authors:  V Shanmugam; V M Chapman; K W Sell; B K Saha
Journal:  Biochem Genet       Date:  1996-02       Impact factor: 1.890

2.  B-lymphocyte heterogeneity: development and characterization of an alloantiserum which distinguishes B-lymphocyte differentiation alloantigens.

Authors:  A Ahmed; I Scher; S O Sharrow; A H Smith; W E Paul; D H Sachs; K W Sell
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

3.  Isotype profiles of anti-influenza antibodies in mice bearing the xid defect.

Authors:  M A Reale; C A Bona; J L Schulman
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

4.  Activation of polyclonal antibody responses by a synthetic serum thymic factor (FTS) in CBA/N mice.

Authors:  T Matsumoto; M Shibata
Journal:  Immunology       Date:  1982-02       Impact factor: 7.397

5.  Cellular and molecular requirements for X-linked, hapten-specific B-cell blockade in CBA/N mice.

Authors:  B Merchant; H Snippe; E F Lizzio; J K Inman
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

6.  Defective colony formation by B lymphocytes from CBA/N and C3H/HeJ mice.

Authors:  P W Kincade
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

7.  Induction of partial chimerism in nonirradiated B-lymphocyte-deficient CBA/N mice.

Authors:  D Volf; L L Sensenbrenner; S J Sharkis; G J Elfenbein; I Scher
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

8.  Role of the thymus in directing the development of a subset of B lymphocytes.

Authors:  J J Mond; I Scher; J Cossman; S Kessler; P K Mongini; C Hansen; F D Finkelman; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

9.  Susceptibility to in vitro tolerance induction of adult B cells from mice with an X-linked B-cell defect.

Authors:  E S Metcalf; I Scher; N R Klinman
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

10.  Antibody response of immunodeficient (xid) CBA/N mice to Escherichia coli 0113 lipopolysaccharide, a thymus-independent antigen.

Authors:  J R Hiernaux; J M Jones; J A Rudbach; F Rollwagen; P J Baker
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.